Diane Williams
Women's Health · Kalamazoo, MINPI 1760608772
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 240 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Among women's health clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$786
- Amgen$524
- Lilly USA, LLC$300
- AstraZeneca$241
- Astellas Pharma US Inc$221
- Biohaven Pharmaceuticals, Inc.$205
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,90598%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 52 | $786 |
| Amgen(2 entities) | 43 | $524 |
| Lilly USA, LLC | 19 | $300 |
| AstraZeneca | 9 | $241 |
| Astellas Pharma US Inc | 8 | $221 |
| Biohaven Pharmaceuticals, Inc. | 13 | $205 |
| GSK | 13 | $186 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $143 |
| Johnson & Johnson | 6 | $115 |
| Pfizer | 7 | $113 |
| AbbVie | 6 | $112 |
| Bayer | 7 | $109 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $102 |
| Insulet Corporation | 4 | $86 |
| Nestle Healthcare Nutrition Inc. | 4 | $79 |
| Daiichi Sankyo Inc. | 3 | $61 |
| GRT US Holding, Inc. | 4 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $59 |
| Ironshore Pharmaceuticals Inc. | 4 | $57 |
| Avanir Pharmaceuticals, Inc. | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Boehringer Ingelheim | 2 | $35 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| Corcept Therapeutics | 1 | $24 |
| Aspira Women's Health Inc | 1 | $23 |
| Nevro Corp. | 1 | $21 |
| Viatris Specialty LLC | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| IBSA Pharma Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$112
How this compares
$4,004 in reported general payments places this provider in the 95th percentile of 91 women's health providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Testosterone Cypionate | 18 | $1,728 |
| Estradiol (Twice Weekly)Estradiol | 15 | $1,667 |
| Spironolactone | 13 | $449 |
Paid to pharmacies, not to this prescriber.
Other women's health in Kalamazoo
- Brittany PostKalamazoo$1K
- Mackenzie ArnoldKalamazoo$1K
- Gail WidenerKalamazoo$222
- Nicole SoveyHartland$8K
- Carol SharpSturgis$4K
- Kimberly Texley-QuiggGrand Rapids$3K
- Bethany BondyTrenton$3K
- Emily ParkerGrand Rapids$3K
- Stephanie BreiningFarmington Hills$2K
- Jennifer AnnettaRoyal Oak$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.